# Hypertension & Anti-Hypertensive Drugs ðŸ©º

---

## What is Hypertension?

- Hypertension = **persistently elevated blood pressure** above normal values.  
- Normal BP: `<120 / <80 mmHg`  
- Hypertension: `â‰¥140 / â‰¥90 mmHg` (sustained).  

**Complications**: Stroke, MI, Heart failure, Chronic kidney disease, Retinopathy.

---

## Goals of Therapy ðŸŽ¯
- Reduce blood pressure to safe levels.  
- Prevent target organ damage (heart, kidney, brain, eyes).  
- Improve survival & quality of life.

---

## Classification of Anti-Hypertensive Drugs ðŸ’Š

| Class | Subtypes | Examples |
|-------|----------|----------|
| **Diuretics** | Thiazides | Hydrochlorothiazide, Chlorthalidone |
| | Loop | Furosemide |
| | Kâº-sparing | Spironolactone, Amiloride |
| **Sympatholytics** | Î²-blockers | Atenolol, Metoprolol, Propranolol |
| | Î±-blockers | Prazosin |
| | Central Î±2 agonists | Clonidine, Methyldopa |
| **Vasodilators** | Direct | Hydralazine, Minoxidil |
| | Calcium channel blockers | Amlodipine, Verapamil, Diltiazem |
| **RAAS Inhibitors** | ACE inhibitors | Enalapril, Ramipril |
| | ARBs | Losartan, Valsartan |
| | Direct renin inhibitor | Aliskiren |

---

## Mechanisms of Action âš™ï¸

```mermaid
flowchart TB
    A[Diuretics] -->|Reduce Naâº & water| B[â†“ Blood Volume]
    B --> C[â†“ Cardiac Output]

    D[Î²-blockers] -->|Block Î²1 receptors| E[â†“ HR & Contractility]
    E --> F[â†“ Cardiac Output]

    G[Î±-blockers] -->|Vasodilation| H[â†“ Peripheral Resistance]

    I[CCBs] -->|Block CaÂ²âº entry| J[Relax Vascular Smooth Muscle]

    K[ACE inhibitors/ARBs] -->|Block RAAS| L[â†“ Ang II, â†“ Aldosterone]
    L --> M[â†“ Vasoconstriction, â†“ Volume]
```

---

## Hypertension Drug Targets Diagram ðŸ—ºï¸

```mermaid
flowchart TB
    Heart((Heart)) -->|Î²-blockers| A[â†“ Cardiac Output]
    Kidney((Kidney)) -->|Diuretics| B[â†“ Volume]
    Vessels((Blood Vessels)) -->|CCBs / Î±-blockers / Vasodilators| C[â†“ Resistance]
    RAAS((RAAS System)) -->|ACEi / ARB / Renin Inhibitor| D[â†“ Ang II, Aldosterone]
```
